CASRAI Dictionary

Tag: group authorship

  • Hyperauthorship and large collaborations: crediting contributions at scale

    Some research papers now carry author lists that run to several pages — thousands of named individuals on a single article, common in particle physics, large-scale genomics, and global clinical consortia. The phenomenon has a name, hyperauthorship, and it puts real pressure on the idea of authorship itself: when the list is that long, what does being “an author” still tell a reader? This article looks at how credit is kept meaningful at that scale, drawing on group-authorship conventions and contributor-role metadata. It connects to the CRediT taxonomy and its fourteen roles, and to the wider group-authorship guidance.

    What hyperauthorship breaks

    The traditional author line works as a signal because it is short enough to read as information: position implies contribution, and a reader can form a view of who did what. Hyperauthorship breaks that signal in two directions at once. The list becomes too long to convey anything about individual contribution — position is meaningless when there are two thousand positions — and at the same time the conventional authorship criteria become hard to apply, because the standard ICMJE requirement that every author be able to take public responsibility for the whole work strains when no single person could possibly have overseen every part of a vast collaboration.

    The result is a genuine tension. Excluding contributors who did essential work would be unjust and would erase the labour that made the result possible. Including everyone as a conventional “author” empties the term of meaning. Large collaborations resolve this not by abandoning credit but by changing how it is structured.

    Consortium and group authorship

    The first mechanism is group (or consortium) authorship. Rather than printing two thousand names on the byline, the article is attributed to a named collaboration — “the SomeStudy Consortium” — with the full list of contributing individuals recorded in a structured way, typically in a collaborator list that is itself indexed so that the individuals remain discoverable and their contribution citable. The named group becomes the author-of-record on the byline, while the individuals are preserved in the metadata.

    This is more than a typographical convenience. It reflects a real fact about the work: the contribution that matters is often the collaboration’s, a collective enterprise with its own governance, membership rules, and authorship policy, sustained across many projects. Treating the consortium as an entity — ideally one that can itself be identified, much as a RAiD identifies a research activity — lets the collective be credited as a collective, while the structured collaborator list ensures individuals are not lost. Indexing services and ORCID support representing membership of such author groups, so an individual can still claim their participation on their own record.

    Contributor roles at scale

    Group authorship answers who was involved; it does not by itself answer who did what. That is where contributorship — recording specific roles rather than a flat “author” label — becomes essential rather than merely nice-to-have. The CRediT taxonomy‘s fourteen roles let a large collaboration record, in structured form, that one group ran the instrument (Investigation, Resources), another built the analysis pipeline (Software, Formal analysis), another curated the shared data (Data curation), and a smaller group drafted the paper (Writing – original draft). The optional degree-of-contribution qualifier — lead, equal, or supporting — adds a further layer, distinguishing those who led a function from the larger number who supported it.

    For a hyperauthored paper, this is the difference between a credit record that is meaningful and one that is not. A flat list of two thousand authors is opaque; the same two thousand contributors mapped to roles — even at the level of teams rather than individuals — tells a reader, a committee, or an indexing system something real about how the work was actually divided. CRediT was designed precisely for this: a small, learnable, structured vocabulary that scales because it describes functions, which remain finite even when contributors do not.

    Practical principles for crediting at scale

    1. Set an authorship and contributorship policy up front. Large collaborations should agree, before results exist, what qualifies someone for the collaborator list, how roles are assigned, and how the consortium is named. Retrofitting credit onto a finished mega-paper is where disputes start.
    2. Use the named-group byline with a structured collaborator list. Attribute the article to the identified collaboration, and record every contributing individual in indexed metadata so they remain discoverable and can claim the work on their ORCID record.
    3. Record roles, not just names. Map contributions to CRediT roles — at team granularity where individual granularity is impractical — so the credit conveys structure, not just headcount.
    4. Make the collaboration itself identifiable. Give the consortium a stable identity (and, where applicable, a project identifier such as RAiD) so its outputs aggregate as a coherent body of work over time.
    5. Keep responsibility explicit. Designate who is accountable for the integrity of the whole and who corresponds — the ICMJE expectation of accountability does not disappear at scale; it has to be assigned deliberately rather than assumed of everyone.

    What stays constant

    It is tempting to treat hyperauthorship as a special case with its own rules, but the underlying principle is the one that governs all credit: contribution should be recorded honestly and in a form that travels. A two-author paper and a two-thousand-author paper face the same question — who contributed what, and how is that preserved so it can be read later — and answer it with the same tools: clear roles, structured metadata, and stable identifiers. Scale changes the mechanics (named groups, indexed collaborator lists, team-level role mapping) but not the goal. Credit at scale is still credit; it just has to be engineered rather than left to the author line.

    Where shared vocabulary fits

    “Author”, “contributor”, “collaborator”, “consortium author”, and “group authorship” are recorded inconsistently across venues, which is exactly how individual contributions to large collaborations get lost. A shared, federated vocabulary that defines these terms precisely — and points back to NISO for the CRediT standard and its degree qualifier, and to ICMJE for the authorship criteria — is what lets a contribution to a mega-collaboration mean the same thing wherever it is read. Supplying that definitional layer is the role the CASRAI dictionary is designed to play; the relevant terms sit in the credit-extensions domain.

    Related reading

  • Authorship in large clinical trials: bylines, groups and the CRediT statement

    A large randomised clinical trial is one of the most collaborative undertakings in research. A single phase III study can involve hundreds of investigators across dozens of sites, plus statisticians, data managers, monitoring committees, and the coordinating centre that holds it all together. Yet the article that reports the result carries a byline that may name only a dozen people. How can a byline that small honestly represent an effort that large? The answer lies in a set of conventions — the ICMJE authorship criteria, group authorship, and a structured contributions statement — that together let a vast, distributed effort be recorded fairly without diluting accountability. This sits squarely in the territory the guidance on group authorship addresses, and it leans heavily on the CRediT roles to do the fine-grained work.

    The ICMJE authorship criteria

    The reference point for who counts as an author of a clinical trial is the International Committee of Medical Journal Editors (ICMJE). The ICMJE recommendations set out four criteria, all of which an individual must meet to qualify for authorship:

    1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data;
    2. Drafting the work or revising it critically for important intellectual content;
    3. Final approval of the version to be published; and
    4. Agreement to be accountable for all aspects of the work, ensuring that questions about its accuracy or integrity are appropriately investigated and resolved.

    The fourth criterion is the one most often forgotten and the most important: authorship is not only credit, it is responsibility. Crucially, the ICMJE is explicit that contributors who meet criterion 1 but not all four should not be authors — they should be acknowledged instead. This is what prevents a trial byline from simply listing everyone who collected data at a site, and it is also why “gift” authorship of senior figures who did not meet the criteria is a breach of the standard rather than a courtesy.

    Group authorship: naming the collaboration

    The criteria create an obvious tension in large trials. Hundreds of people made genuine, substantial contributions, but they cannot all meet every criterion, and a byline of three hundred names would be unusable. Group authorship is the ICMJE-sanctioned solution. A trial is published under the name of the study group — for example, “the EXAMPLE-2 Trial Investigators” — and the article distinguishes between two categories of people:

    • Named authors who individually meet all four ICMJE criteria and take direct responsibility for the manuscript. These may be listed in the byline alongside the group name, or the group name itself may carry the authorship with the qualifying individuals identified.
    • Collaborators — the wider membership of the study group who contributed substantially to the trial but do not individually meet all four authorship criteria. They are listed by name, typically in an appendix or supplementary file, and are indexed by databases such as PubMed as collaborators rather than authors.

    This is not a way of demoting people. It is a way of telling the truth about a collaboration: a clear, public record that this person was a named author who is accountable for the paper, and that person was a collaborating investigator whose site recruited patients and whose work made the trial possible. The ICMJE asks that the journal specify, somewhere in the article, exactly who is responsible in each category, so that the byline cannot be read as either inflating or erasing anyone’s role.

    The CRediT statement: who did what

    Group authorship answers who is accountable; it does not, by itself, answer who did what. That is the job of a structured contributions statement built on the CRediT taxonomy. CRediT supplies fourteen standard roles — Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – original draft, Writing – review & editing, Visualization, Supervision, Project administration, and Funding acquisition — and a clinical trial maps onto them unusually cleanly:

    • Conceptualization and Methodology capture the people who designed the trial and its protocol.
    • Investigation records the site investigators who recruited and assessed participants — the role that most collaborating investigators occupy.
    • Data curation records the data managers who cleaned and maintained the trial database.
    • Formal analysis records the statisticians who ran the pre-specified analyses.
    • Project administration records the coordinating-centre staff who ran the trial day to day.
    • Funding acquisition records those who secured the grant that paid for it.

    A CRediT statement turns the contributions section from a vague paragraph of thanks into machine-readable data. For a named author it can specify a degree of contribution — lead, equal, or supporting — so that the chief investigator’s role in Conceptualization is distinguished from a co-author’s supporting role. Used well, it means that a reader, a hiring committee, or a CRIS system can see precisely how the labour of a trial was divided, rather than inferring it from author order alone.

    Why this matters for accountability

    Clinical trials carry unusual weight: their results change clinical practice and affect patients. That raises the stakes of the fourth ICMJE criterion. When questions are later raised about a trial — a data discrepancy, an unreproducible analysis, a query about a particular site — the structured record of authorship and contribution is what makes accountability tractable. Knowing who took responsibility as a named author, who curated the data, and who ran the statistics localises responsibility rather than diffusing it across an anonymous group. A trial that is published under a study-group name and carries both a clear statement of named authors and a CRediT breakdown is far more accountable than one with a long, undifferentiated byline.

    Practical guidance for trial teams

    1. Decide authorship against the ICMJE criteria, not seniority or site. Meeting criterion 1 alone makes someone a collaborator, not an author.
    2. Adopt a group name and a written authorship policy early — ideally in the protocol — so that expectations are set before the data exist and disputes are pre-empted.
    3. List collaborators by name. Being a collaborating investigator is a real, indexed, citable contribution; do not bury it.
    4. Publish a CRediT statement mapping each named author to their roles, with degree-of-contribution where it clarifies who led what.
    5. Attach ORCID iDs to named authors and, where possible, collaborators, so that the contribution propagates to each person’s record rather than being lost to a generic group name.

    Where shared vocabulary fits

    “Author”, “collaborator”, “investigator”, “study group”, and “contributor” are used inconsistently across trials and journals, which is part of why trial bylines are so often misread. A shared, federated vocabulary that defines these terms precisely — and points back to the ICMJE recommendations and the CRediT taxonomy — is what lets a group-authored trial in one journal be understood the same way in another. Supplying that definitional layer is the role the CASRAI dictionary is designed to play.

    Related reading